Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 5
2012 3
2013 3
2014 4
2015 4
2016 4
2017 1
2018 4
2019 7
2020 7
2021 6
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
CD38 as a multifaceted immunotherapeutic target in CLL.
Paulus A, Malavasi F, Chanan-Khan A. Paulus A, et al. Leuk Lymphoma. 2022 Oct;63(10):2265-2275. doi: 10.1080/10428194.2022.2090551. Epub 2022 Aug 17. Leuk Lymphoma. 2022. PMID: 35975791 Review.
Novel therapeutic targets in Waldenstrom macroglobulinemia.
Paulus A, Ailawadhi S, Chanan-Khan A. Paulus A, et al. Best Pract Res Clin Haematol. 2016 Jun;29(2):216-228. doi: 10.1016/j.beha.2016.08.020. Epub 2016 Sep 7. Best Pract Res Clin Haematol. 2016. PMID: 27825468 Review.
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies.
Mondello P, Paludo J, Novak JP, Wenzl K, Yang ZZ, Jalali S, Krull JE, Braggio E, Dasari S, Manske MK, Abeykoon JA, Sarangi V, Kapoor P, Paulus A, Reeder CB, Ailawadhi S, Chanan-Khan AA, Kyle RA, Gertz MA, Novak AJ, Ansell SM. Mondello P, et al. Among authors: paulus a. Clin Cancer Res. 2023 Mar 1;29(5):957-970. doi: 10.1158/1078-0432.CCR-22-2215. Clin Cancer Res. 2023. PMID: 36534518
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.
Deng J, Paulus A, Fang DD, Manna A, Wang G, Wang H, Zhu S, Chen J, Min P, Yin Y, Dutta N, Halder N, Ciccio G, Copland JA, Miller J, Han B, Bai L, Liu L, Wang M, McEachern D, Przybranowski S, Yang CY, Stuckey JA, Wu D, Li C, Ryan J, Letai A, Ailawadhi S, Yang D, Wang S, Chanan-Khan A, Zhai Y. Deng J, et al. Among authors: paulus a. Clin Cancer Res. 2022 Dec 15;28(24):5455-5468. doi: 10.1158/1078-0432.CCR-21-4037. Clin Cancer Res. 2022. PMID: 36048524
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial.
Ailawadhi S, Chen Z, Huang B, Paulus A, Collins MC, Fu LT, Li M, Ahmad M, Men L, Wang H, Davids MS, Liang E, Mekala DJ, He Z, Lasica M, Yannakou CK, Parrondo R, Glass L, Yang D, Chanan-Khan A, Zhai Y. Ailawadhi S, et al. Among authors: paulus a. Clin Cancer Res. 2023 Jul 5;29(13):2385-2393. doi: 10.1158/1078-0432.CCR-22-3321. Clin Cancer Res. 2023. PMID: 37074726 Free PMC article.
The Circular Life of Human CD38: From Basic Science to Clinics and Back.
Horenstein AL, Faini AC, Morandi F, Bracci C, Lanza F, Giuliani N, Paulus A, Malavasi F. Horenstein AL, et al. Among authors: paulus a. Molecules. 2020 Oct 21;25(20):4844. doi: 10.3390/molecules25204844. Molecules. 2020. PMID: 33096610 Free PMC article. Review.
53 results